Titlebook: Radiopharmaceutical Therapy; Lisa Bodei,Jason S. Lewis,Brian M. Zeglis Book 2023 The Editor(s) (if applicable) and The Author(s), under ex

只看該作者 · 發(fā)表于 2025-3-23 11:06:09

Case Study #4: Lutathera, a Gold Standard for Peptide Receptor Radiopharmaceutical Therapyata from the most important work in this field, the phase III NETTER-1 trial, which showed that the treatment of unresectable/metastatic progressive small bowel NETs with Lutathera. resulted in a significant improvement in progression-free survival (PFS) and overall survival (OS) compared with high-

只看該作者 · 發(fā)表于 2025-3-23 14:03:50

只看該作者 · 發(fā)表于 2025-3-23 21:02:39

只看該作者 · 發(fā)表于 2025-3-24 01:44:22

只看該作者 · 發(fā)表于 2025-3-24 02:39:42

Book 2023eview process for radiotherapeutics..This book is the first of its kind andis useful for a broad audience of scientists, researchers, physicians, and students across a range of fields, including biochemistry, cancer biology, nuclear medicine, radiology, and radiation oncology..

只看該作者 · 發(fā)表于 2025-3-24 07:57:48

只看該作者 · 發(fā)表于 2025-3-24 13:59:04

Ganesan Vaidyanathan,Yutian Feng,Michael R. Zalutsky

只看該作者 · 發(fā)表于 2025-3-24 15:05:44

只看該作者 · 發(fā)表于 2025-3-24 23:00:17

Nai-Kong V. Cheung,Kim Kramer,Shakeel Modak,Brian H. Kushner,Mahiuddin Ahmed,Brian Santich,Sarah Che

只看該作者 · 發(fā)表于 2025-3-24 23:34:41

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 22:36
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved